Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety, Tolerability, Pharmacokinetics, and Food Impact Phase I Study of GST-HG151 Tablets in Single-dose and Multiple-dose in Healthy Volunteers

NCT05345964 is registered in ClinicalTrials.gov with Fujian Cosunter Pharmaceutical Co. Ltd as lead sponsor.

NCT NCT05345964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05345964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety, Tolerability, Pharmacokinetics, and Food Impact Phase I Study of GST-HG151 Tablets in Single-dose and Multiple-dose in Healthy Volunteers
Lead sponsor
Fujian Cosunter Pharmaceutical Co. Ltd
Phase
Phase 1
Overall status
Unknown status
Start date
March 7, 2022
Completion date
May 31, 2023
Enrollment
112 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers